Summit Global Investments - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 2 filers reported holding ROYALTY PHARMA PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$303
-94.4%
11,179
-93.6%
0.02%
-94.4%
Q2 2023$5,363
+5.3%
174,450
+23.4%
0.36%
-9.9%
Q1 2023$5,094
-6.7%
141,381
+2.3%
0.39%
-14.5%
Q4 2022$5,462
-99.9%
138,200
+0.4%
0.46%
-9.8%
Q3 2022$5,530,000
-5.0%
137,619
-0.6%
0.51%
-0.4%
Q2 2022$5,823,000
+12.4%
138,510
+4.2%
0.51%
+34.3%
Q1 2022$5,180,000132,9650.38%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders